Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Cash from Investing Activities

Gilead Sciences Inc Cash from Investing Activities Chart (GILD)

Gilead Sciences Inc annual/quarterly Cash from Investing Activities from 2010 to 2020.
  • Gilead Sciences Inc Cash from Investing Activities for the quarter ending September 09, 2020 was $-271m a 259.04% decrease of -702m year over year
  • Gilead Sciences Inc Cash from Investing Activities for the last 12 months ending September 09, 2020 was $-5,207m a -50.12% increase of 2,610m year over year
  • Gilead Sciences Inc Annual Cash from Investing Activities for 2019 was $-7,817m a 283.64% decrease of -22,172m from 2018
  • Gilead Sciences Inc Annual Cash from Investing Activities for 2018 was $14,355m a 211.94% increase of 30,424m from 2017
  • Gilead Sciences Inc Annual Cash from Investing Activities for 2017 was $-16,069m a 25.42% decrease of -4,084m from 2016
Other Cash Flow Metrics:
  • Gilead Sciences Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $2,212m a -24.46% decrease of -541m year over year
  • Gilead Sciences Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,592m a -123.19% decrease of -1,962m year over year
  • Gilead Sciences Inc Total Revenue for the quarter ending December 12, 2018 was $5,795m a 12.20% increase of 707m year over year
View Chart On Koyfin

Quarterly GILD Cash from Investing Activities Data

09/2020$-271m
06/2020$-5,023m
03/2020$-344m
12/2019$431m
09/2019$-1,841m
06/2019$-6,163m
03/2019$-244m
12/2018$2,735m
09/2018$2,025m
06/2018$5,241m

Annual GILD Cash from Investing Activities Data

2019$-7,817m
2018$14,355m
2017$-16,069m
2016$-11,985m
2015$-12,475m
2014$-1,823m
2013$-254m
2012$-11,846m
2011$3,590m
2010$-1,938m